Pleiadian Pharma Private Limited
About Pleiadian Pharma Private Limited
Data last updated:
Pleiadian Pharma Private Limited is a private limited company based in Delhi, India. It operates in the animal health services segment of the veterinary services sector. It was incorporated on 15 July 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U85200DL2016PTC303086.
The company has an authorised share capital of ₹2 Lakh and a paid-up capital of ₹2 Lakh. It is led by directors including Ajay Kumar Agrawal and Anil Kumar Agrawal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at B – 5 Second Floor Shiva Chamber Nimri Colony Commercial Complex Ashok Vihar Phase – 4, Delhi, India – 110052.
As per the financials filed for FY 2025, the company reported a revenue of ₹10.85 Lakh, a decline of 22% compared to the previous year. For the same year it recorded a net profit of ₹30,050 (net margin 2.8%) and EBITDA of ₹46,351 (EBITDA margin 4.3%). Revenue has declined at a compounded annual rate (CAGR) of 17% over three years and 25% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Pleiadian Pharma Private Limited's registered office is in Delhi, Delhi.
- Registered AddressB – 5 Second Floor Shiva Chamber Nimri Colony Commercial Complex Ashok Vihar Phase – 4, Delhi, India – 110052
- IndustryVeterinary, Animal Health Services
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Pleiadian Pharma is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations |
To see the full business activity and turnover split of Pleiadian Pharma Private Limited, buy the company report.
Financials of Pleiadian Pharma Private Limited
FY 2025 filings availablePleiadian Pharma Private Limited reported revenue of ₹10.85 Lakh (down 22% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 25% over five years, including a 22% fall in the latest year. EBITDA rose 1% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹46,351 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹30,050 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.3% | ||||
| Net Profit Margin | 2.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Pleiadian Pharma Private Limited, buy the company report.
Board of directors of Pleiadian Pharma Private Limited
Pleiadian Pharma has 5 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ajay Kumar Agrawal | Director | 13 Sep 2018 | 8 Years 1 Months | Current |
| Anil Kumar Agrawal | Director | 13 Sep 2018 | 8 Years 1 Months | Current |
| Eshwar Prasad Jumpala | Director | 13 Sep 2018 | 8 Years 1 Months | Current |
| Sanket Kumar Agrawal | Director | 13 Sep 2018 | 8 Years 1 Months | Current |
| Asim Kumar Agrawal | Director | 13 Sep 2018 | 8 Years 1 Months | Current |
Peer comparison
Pleiadian Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (manufacture of basic pharmaceutical products and pharmaceutical preparations), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| RJMS Agro Private Limited | ₹11.22 Lakh (FY 2024) | Vasai, Maharashtra, India | ||||
| Atoffy Lifesciences Private Limited | ₹11.04 Lakh (FY 2025) | New Delhi, Delhi, India | ||||
| Santrash Private Limited | ₹10.97 Lakh (FY 2024) | 694.0% | Delhi, India | |||
| Pooja Agro Chemicals and Fertilizers Private Limited | ₹10.89 Lakh (FY 2025) | -3.0% | Nashik, Maharashtra, India | |||
| Pintu's PP Products Private Limited | ₹10.89 Lakh (FY 2025) | Thane, Maharashtra, India | ||||
| Pleiadian Pharma Private Limitedthis company | ₹10.85 Lakh (FY 2025) | ₹30,050 | 2.8% | -22.0% | Delhi, India | |
| Scoots Pharmaceutical Private Limited | ₹10.77 Lakh (FY 2025) | 161.0% | Delhi, India | |||
| Maxlead Sciences Private Limited | ₹10.58 Lakh (FY 2024) | Surat, Gujarat, India | ||||
| Ecostar Pharmaceuticals Private Limited | ₹10.53 Lakh (FY 2025) | 12.0% | Chalisgaon, Maharashtra, India | |||
| Vetify Private Limited | ₹10.27 Lakh (FY 2024) | 2370.0% | Varanasi, Uttar Pradesh, India | |||
| Dattatreya Ayurveda Herbs Private Limited | ₹10.26 Lakh (FY 2025) | Nadiad, Gujarat, India |
To see the full peer comparison of Pleiadian Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Pleiadian Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Pleiadian Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Pleiadian Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Pleiadian Pharma Private Limited has 9 board changes on record since 2016: 7 appointments and 2 cessations. The latest: Rajneesh Gupta ceased to be Director on 05 Feb 2019.
Frequently asked questions
Pleiadian Pharma is an active private limited company based in Delhi, India. The company works in animal health services, within the veterinary industry. It was incorporated on 15 July 2016 (10+ years old) and is registered under CIN U85200DL2016PTC303086.
Pleiadian Pharma has 5 current directors:
- Ajay Kumar Agrawal - Director
- Anil Kumar Agrawal - Director
- Eshwar Prasad Jumpala - Director
- Sanket Kumar Agrawal - Director
- Asim Kumar Agrawal - Director
The latest financial statements of Pleiadian Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.
The CIN (Corporate Identification Number) of Pleiadian Pharma is U85200DL2016PTC303086. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Pleiadian Pharma was incorporated on 15 July 2016, making it 10+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Pleiadian Pharma by revenue are RJMS Agro Private Limited, Atoffy Lifesciences Private Limited, Santrash Private Limited, Pooja Agro Chemicals and Fertilizers Private Limited, Pintu's PP Products Private Limited and 5 more, all in the same principal business activity (manufacture of basic pharmaceutical products and pharmaceutical preparations).
Rajneesh Gupta ceased to be Director on 05 Feb 2019. Saumil Anand Gupta ceased to be Director on 05 Feb 2019. Ajay Kumar Agrawal was appointed as Director on 13 Sep 2018. Pleiadian Pharma has 9 board changes on record in total.
The registered office of Pleiadian Pharma is at B – 5 Second Floor Shiva Chamber Nimri Colony Commercial Complex Ashok Vihar Phase – 4, Delhi, India – 110052.
Pleiadian Pharma operates in the veterinary industry, in the animal health services segment.
The compliance status of Pleiadian Pharma is compliant as of 01 August 2026. The company is actively filing with the Registrar of Companies.
Pleiadian Pharma can be reached at its registered office: B – 5 Second Floor Shiva Chamber Nimri Colony Commercial Complex Ashok Vihar Phase – 4, Delhi, India – 110052.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
